Company news

ADVANZ PHARMA Corp. Limited news in 2020

ADVANZ PHARMA Corp. Limited's news releases, calls and decks from 2020, newest first.

View company

ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results

November 6, 2020

ADVANZ Pharma Corp. Limited ("ADVANZ" or the "Company") - Formal Sale Process

October 23, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results

October 23, 2020

ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results

August 12, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results

July 29, 2020

ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders

June 17, 2020

Correvio Provides Update Pursuant to BCI 51-515 - Temporary Exemption from Certain Corporate Finance Requirements

June 15, 2020

ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.

May 27, 2020

ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results

May 13, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results

April 29, 2020

ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million

April 1, 2020

ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange

March 27, 2020

ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results

March 25, 2020

ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.

March 16, 2020

ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results

March 11, 2020

ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange

March 10, 2020

ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

March 6, 2020

ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets

February 12, 2020

ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe

January 8, 2020